2013 Research Awards
Dr. Shawn Christ,
Associate Professor of Psychological Sciences and Associate Director of the Brain Imaging Center at the University of Missouri, will examine the effects of PKU on gray matter structures in the brain.
Dr. Donna Santillan and her lab at the University of Iowa Hospitals and Clinics have been developing an artificial organ system by encapsulating HepG2 cells to treat PKU.
Genetic Metabolic Dietitians International (GMDI) will work to improve nutrition outcomes in PKU through a research project to develop national standards for nutrition management of PKU.
Dr. K. Michael Gibson, Professor and Chair, Dept. of Biological Sciences at Michigan Tech University, will continue to research an approach to PKU therapy that examines the ability of non-physiological amino acids (NPAAs) to lower brain phe levels and thereby restore brain amino acid equilibrium.
Dr. Hunt von Herbing, Associate Professor in Department of Biological Sciences, University of North Texas, Denton, Texas & Katherine Deming, MS, Ph.D. Candidate and Project Leader will continue their innovative study entitled, "Genetically Engineered Probiotics for the Treatment of PKU." Their research on PKU mice will focus on allowing altered probiotic bacteria to compensate for the lack of functional PAH.
Click here for full summaries of the 2013 research projects.